Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

Medtronic (MDT) Stock Price & Analysis

MDT Stock Chart & Stats

$96.54-$0.57(-0.59%)
At close: 4:00 PM EDT
$85$90$953 Aug17 Aug31 Aug14 Sep28 Sep12 Oct26 Oct
Day’s Range
$96.46 - $98.09
52-Week Range
$73.31 - $106.33
Previous Close
$97.11
Volume
1.79M
Average Volume (3M)
26.09M
Market Cap
$123.49B
Enterprise Value
$129.69B
Total Cash (Recent Filing)
$8.82B
Total Debt (Recent Filing)
$28.15B
Price to Earnings (P/E)
23.6
Beta
0.29
Next Earnings
Nov 24, 2026 (Est.)
EPS Estimate
1.33
Last Dividend Ex-Date
Sep 25, 2026
Dividend Yield
2.96%

Bulls Say, Bears Say

Bulls Say

Cash Generation

Strong operating and free cash flow provide Medtronic with durable internal funding for research, acquisitions, debt service, and shareholder returns. The 13% increase in free cash flow also supports resilience and gives management flexibility to invest through changing procedure and reimbursement environments.

Raised Growth Guidance

Higher full-year growth and profit guidance indicates management sees broad-based demand and operating leverage extending beyond a single product or quarter. Expected margin expansion alongside revenue growth suggests the portfolio can convert improved commercial momentum into stronger earnings over coming periods.

Cardiac Ablation Momentum

Exceptional cardiac ablation growth and measurable share gains strengthen Medtronic’s position in an important therapy category. The expanding Affera and Sphere-9 platform can support recurring procedure-driven revenue, deepen physician adoption, and create a durable foundation for future electrophysiology expansion.

Bears Say

Elevated Debt

Although equity supports a moderate debt-to-equity profile, the sizable absolute debt balance can reduce financial flexibility if growth slows or capital costs rise. Higher leverage may constrain acquisition capacity, increase refinancing exposure, and compete with innovation or shareholder-return priorities.

Cash Conversion Pressure

Operating cash flow below reported earnings suggests working-capital or timing factors are limiting near-term cash realization. If this persists, it could weaken the reliability of accounting profits as a funding source and reduce flexibility for investment, debt reduction, and capital allocation.

Neuromodulation Weakness

Slow neuromodulation growth indicates pressure in an established portfolio, with both market softness and replacement dynamics affecting demand. Continued weakness could restrain Neuroscience performance, dilute growth from stronger businesses, and require additional innovation or commercial investment to restore momentum.

Medtronic News

MDT FAQ

What was Medtronic’s price range in the past 12 months?
Medtronic lowest stock price was $73.31 and its highest was $106.33 in the past 12 months.
What is Medtronic’s market cap?
Medtronic’s market cap is $123.49B.
When is Medtronic’s upcoming earnings report date?
Medtronic’s next earnings report is estimated for Nov 24, 2026 (not yet confirmed), which is in 22 days.
How were Medtronic’s earnings last quarter?
Medtronic released its earnings results on Sep 01, 2026. The company reported $1.45 earnings per share for the quarter, beating the consensus estimate of $1.388 by $0.062.
Is Medtronic overvalued?
According to Wall Street analysts Medtronic’s price is currently Undervalued.
Does Medtronic pay dividends?
Medtronic pays a Quarterly dividend of $0.72 which represents an annual dividend yield of 2.96%. See more information on Medtronic dividends here
What is Medtronic’s EPS estimate?
Medtronic’s EPS estimate is 1.33.
How many shares outstanding does Medtronic have?
Medtronic has 1,279,169,900 shares outstanding.
What happened to Medtronic’s price movement after its last earnings report?
Medtronic reported an EPS of $1.45 in its last earnings report, beating expectations of $1.388. Following the earnings report the stock price went up 1.534%.
Which hedge fund is a major shareholder of Medtronic?
Hedge funds hold Medtronic shares: the largest hedge-fund position in Medtronic is 71,885,804 shares, and hedge funds increased their holdings by 5.5M shares last quarter.
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology